Bora CDMO Bora CDMO

X

Find Norfluoxetine manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

0

US DMFs Filed

US DMFs Filed

0

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

0

Other Suppliers

Other Suppliers

0

API REF. PRICE (USD / KG)

0

INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

0

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES
MolPort-002-052-043
Also known as: 83891-03-6, Desmethylfluoxetine, 56161-73-0, 3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine, 3-phenyl-3-(4-(trifluoromethyl)phenoxy)propan-1-amine, 3-phenyl-3-(4-trifluoromethyl-phenoxy)-propylamine
Molecular Formula
C16H16F3NO
Molecular Weight
295.30  g/mol
InChI Key
WIQRCHMSJFFONW-UHFFFAOYSA-N
FDA UNII
K8D70XE2F4

1 2D Structure

MolPort-002-052-043

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine
2.1.2 InChI
InChI=1S/C16H16F3NO/c17-16(18,19)13-6-8-14(9-7-13)21-15(10-11-20)12-4-2-1-3-5-12/h1-9,15H,10-11,20H2
2.1.3 InChI Key
WIQRCHMSJFFONW-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1=CC=C(C=C1)C(CCN)OC2=CC=C(C=C2)C(F)(F)F
2.2 Other Identifiers
2.2.1 UNII
K8D70XE2F4
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Desmethylfluoxetine

2. Norfluoxetin

3. Norfluoxetine Hydrochloride

4. Norfluoxetine, (+-)-isomer

2.3.2 Depositor-Supplied Synonyms

1. 83891-03-6

2. Desmethylfluoxetine

3. 56161-73-0

4. 3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine

5. 3-phenyl-3-(4-(trifluoromethyl)phenoxy)propan-1-amine

6. 3-phenyl-3-(4-trifluoromethyl-phenoxy)-propylamine

7. K8d70xe2f4

8. Benzenepropanamine, Gamma-(4-(trifluoromethyl)phenoxy)-

9. Benzenepropanamine, Gamma-[4-(trifluoromethyl)phenoxy]-

10. Unii-k8d70xe2f4

11. Gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine

12. Chembl1494

13. Gtpl208

14. Schembl686500

15. Dtxsid80866540

16. Chebi:180876

17. (+/-)-desmethylfluoxetine

18. Bcp20944

19. Bdbm50180661

20. Nsc675448

21. Akos015911091

22. Norfluoxetine Hcl;n-desmethylfluoxetine

23. Nsc-675448

24. Sb32578

25. Sb32682

26. Sb38941

27. Ft-0673087

28. Ft-0673088

29. Ft-0673089

30. 3-(4-trifluoromethylphenoxy)-3-phenylproplyamine

31. A840679

32. L001023

33. Q7452012

34. 3-phenyl-3-[4-(triluoromethyl)phenoxy]propan-1-amine

35. 3-phenyl-3[4'-trifluoromethyl-phenoxy]-propan-1-amine

36. 3-phenyl-3-[4-(trifluoromethyl)phenoxy]-1-propanamine #

37. Benzenepropanamine, .gamma.-[4-(trifluoromethyl)phenoxy]-

38. Benzenepropanamine, Gamma-[4-(trifluoromethyl)phenoxy]-, (+/-)-

39. Benzenepropanamine, .gamma.-(4-(trifluoromethyl)phenoxy)-, (+/-)-

2.4 Create Date
2005-03-25
3 Chemical and Physical Properties
Molecular Weight 295.30 g/mol
Molecular Formula C16H16F3NO
XLogP33.5
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count5
Rotatable Bond Count5
Exact Mass295.11839862 g/mol
Monoisotopic Mass295.11839862 g/mol
Topological Polar Surface Area35.2 Ų
Heavy Atom Count21
Formal Charge0
Complexity294
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 Metabolism/Metabolites

Norfluoxetine is a known human metabolite of Fluoxetine.

S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560


Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY